Zobrazeno 1 - 10
of 910
pro vyhledávání: '"Roué G"'
Autor:
Martínez-Asensio M; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Sàrrias L; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Gorjón-de-Pablo G; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain.; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, E-08916 Badalona, Spain., Fernández-Serrano M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, E-08916 Badalona, Spain., Camaló-Vila J; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Gibert A; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Puig de la Bellacasa R; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Teixidó J; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, E-08916 Badalona, Spain., Borrell JI; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain., Estrada-Tejedor R; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Aug 30; Vol. 25 (17). Date of Electronic Publication: 2024 Aug 30.
Autor:
Campillo-Marcos I; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain., Casado-Pelaez M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Ferrer G; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain., Mata C; Single Cell Unit, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain., Mereu E; Cellular Systems Genomics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Valcárcel D; Department of Hematology, Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Catalonia, Spain., Molero A; Department of Hematology, Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Catalonia, Spain., Zamora L; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Spain.; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Xicoy B; Department of Hematology, ICO-IJC-Hospital Germans Trias i Pujol, UAB, Badalona, Spain.; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Palomo L; Department of Hematology, Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Catalonia, Spain.; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Acha P; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Manzanares A; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Tobiasson M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden., Hellström-Lindberg E; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden; Medical Unit Hematology, Karolinska University Hospital, Stockholm, Sweden., Solé F; Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain., Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Feb 12; Vol. 4 (2), pp. 365-377.
Autor:
Caillot M; Normandie Univ, INSERM, Unicaen, Caen, France., Miloudi H; Normandie Univ, INSERM, Unicaen, Caen, France., Taly A; Laboratoire de Biochimie Théorique, CNRS, Université de Paris, Paris, France.; Institut de Biologie Physico-Chimique, Fondation Edmond de Rothschild, PSL Research University, Paris, France., Profitós-Pelejà N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Santos JC; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Ribeiro ML; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Maitre E; Normandie Univ, INSERM, Unicaen, Caen, France.; Laboratoire d'hématologie, CHU Côte de Nacre, Caen, France., Saule S; Institut Curie, PSL Research University, CNRS, INSERM, Orsay, France.; Université Paris-Sud, Université Paris-Saclay, CNRS, INSERM, Orsay, France., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Jardin F; Normandie Univ, INSERM, Unirouen, Rouen, France.; Service d'hématologie, Centre de lutte contre le cancer Henri Becquerel, Rouen, France., Sola B; Normandie Univ, INSERM, Unicaen, Caen, France.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Dec; Vol. 17 (12), pp. 2546-2564. Date of Electronic Publication: 2023 Apr 21.
Autor:
Witte HM; Department of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany.; University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany., Künstner A; University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany.; Medical Systems Biology Group, University of Lübeck, Lübeck, Germany., Chteinberg E; Institute of Human Genetics Ulm University and Ulm University Medical Center, Ulm, Germany., Piazza F; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova and Myeloma and Lymphoma Pathobiology Laboratory, Veneto Istituto of Molecular Medicine, Padova, Italy., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Gebauer N; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, Lübeck, Germany.; University Cancer Center Schleswig-Holstein, University Hospital of Schleswig-Holstein, Lübeck, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1278169. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Autor:
Sabatier M; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Birsen R; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland.; Université de Paris, Institut Cochin, CNRS U8104, Inserm U1016, Paris, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Service d'Hématologie Clinique, Paris, France., Lauture L; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Mouche S; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland., Angelino P; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Dehairs J; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI-Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Goupille L; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Boussaid I; Université de Paris, Institut Cochin, CNRS U8104, Inserm U1016, Paris, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Heiblig M; Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.; CIRI, Inserm U1111 CNRS 5308, Université Lyon 1, Lyon, France., Boet E; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Sahal A; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Saland E; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Santos JC; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Armengol M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Fernández-Serrano M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Farge T; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Cognet G; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Simonetta F; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland., Pignon C; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Graffeuil A; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Mazzotti C; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Avet-Loiseau H; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Delos O; MetaboHUB-MetaToul, National Infrastructure of Metabolomics and Fluxomics, University Paul Sabatier, Toulouse, France., Bertrand-Michel J; MetaboHUB-MetaToul, National Infrastructure of Metabolomics and Fluxomics, University Paul Sabatier, Toulouse, France., Chedru A; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, MetaboHUB, Gif sur Yvette, France., Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Anstee NS; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Australia., Loo S; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Wei AH; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, University of Melbourne, Parkville, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Carroll M; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Goubard A; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Castellano R; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Collette Y; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France., Vergez F; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Mansat-De Mas V; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Bertoli S; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Tavitian S; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Picard M; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service de Réanimation, Toulouse, France., Récher C; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France.; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Service d'Hématologie, Toulouse, France., Bourges-Abella N; CREFRE, Universite de Toulouse, Inserm, ENVT, UPS, Toulouse., Granat F; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Kosmider O; Université de Paris, Institut Cochin, CNRS U8104, Inserm U1016, Paris, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Sujobert P; Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.; CIRI, Inserm U1111 CNRS 5308, Université Lyon 1, Lyon, France., Colsch B; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé, MetaboHUB, Gif sur Yvette, France., Joffre C; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Stuani L; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France., Swinnen JV; Laboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI-Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Guillou H; Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, University Paul Sabatier, Toulouse, France., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Hakim N; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITy), Inserm UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France., Dejean AS; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITy), Inserm UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France., Tsantoulis P; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Larrue C; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland., Bouscary D; Université de Paris, Institut Cochin, CNRS U8104, Inserm U1016, Paris, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Service d'Hématologie Clinique, Paris, France., Tamburini J; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, and Swiss Cancer Center Leman, Geneva, Switzerland.; Université de Paris, Institut Cochin, CNRS U8104, Inserm U1016, Paris, France.; Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Sarry JE; Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, Inserm U1037, CNRS U5077, Toulouse, France.; LabEx Toucan, Toulouse, France.; Équipe Labellisée Ligue Nationale Contre le Cancer 2018, Toulouse, France.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Jul 07; Vol. 13 (7), pp. 1720-1747.
Autor:
Ribeiro ML; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.; Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil., Sánchez Vinces S; Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil., Mondragon L; T Cell Lymphoma Group, Josep Carreras Leukaemia Research Institute, IJC. Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute, IJC. Ctra de Can Ruti, Camí de les Escoles s/n, 08916 Badalona, Barcelona, Spain.
Publikováno v:
Therapeutic advances in hematology [Ther Adv Hematol] 2023 May 30; Vol. 14, pp. 20406207231173485. Date of Electronic Publication: 2023 May 30 (Print Publication: 2023).
Autor:
Ribeiro ML; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain.; Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, São Paulo, Brazil., Profitós-Pelejà N; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain., Santos JC; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain., Blecua P; Cancer Epigenetics Group, Josep Carreras Leukemia Research Institute, Badalona, Spain., Reyes-Garau D; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain., Armengol M; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain., Fernández-Serrano M; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain., Miskin HP; TG Therapeutics, New York, NY, United States., Bosch F; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain.; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Esteller M; Cancer Epigenetics Group, Josep Carreras Leukemia Research Institute, Badalona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Normant E; TG Therapeutics, New York, NY, United States., Roué G; Lymphoma Translational Group, Josep Carreras Leukemia Research Institute, Badalona, Spain.; Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona, Barcelona, Spain.; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Apr 21; Vol. 14, pp. 1130052. Date of Electronic Publication: 2023 Apr 21 (Print Publication: 2023).
Autor:
Marín Soria JL, López Galera RM, Argudo Ramírez A, González de Aledo JM, Pajares García S, Navarro Sastre A, Hernandez Pérez JM, Ribes Rubio A, Gort Mas L, García Villoria J, Gartner Tizano S, Rovira Amigo S, Asensio de la Cruz O, García González M, Cols M, Costa-Colomer J, Bádenas Orquin C, Yeste Fernández D, Campos Martorell A, Clemente León M, Mogas Viñals E, Ferrer Costa R, Giralt Arnaiz M, Campistol-Plana J, Garcia-Cazorla A, Beneitez Pastor D, Ortuño Cabrero A, Blanco Álvarez A, Tazón Vega B, Roué G, Velasco Puyo P, Murciano Carrillo T, Murillo Sanjuan L, Díaz de Heredia Rubio C, Mañú Pereira MDM, Vives Corrons JL, Arranz Amo JA, Carnicer Cáceres C, Del Toro Riera M, Ormazábal Herrero A, Artuch-Iriberri R, García-Volpe C, de los Santos MM, Sierra-March C, Ruiz-Hernández CJ, Meavilla-Olivas SM, Martín Nalda A, Rivière JG, Parra Martínez A, Soler Palacín P, Martínez Gallo M, Colobran R, Casals Senent T, Armelles Sebastia M, Vidal Benede MJ, Jané Checa M, Fernández Bordón RM, Asso Ministral L, Prats Viedma B, Cabezas Peña C
Publikováno v:
Revista espanola de salud publica
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
The Catalonian Newborn Screening Program (CNSP) began in 1969, in Barcelona. It was promoted by Dr. Juan Sabater Tobella and supported by Barcelona Provincial Council and Juan March Foundation. That is how the Institute of Clinical Biochemistry was b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b7dbd4e923c96b383eb2da77f0c4486c
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18510
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18510
Autor:
Santos JC; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain., Profitós-Pelejà N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain., Sánchez-Vinces S; Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista 01246-100, São Paulo, Brazil., Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Spain.
Publikováno v:
Cells [Cells] 2023 Jan 28; Vol. 12 (3). Date of Electronic Publication: 2023 Jan 28.
Autor:
Montagut AM; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Armengol M; Lymphoma Translational Group, UBIRed, Josep Carreras Leukaemia Research Institute, Badalona, Spain., de Pablo GG; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Estrada-Tejedor R; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain., Borrell JI; Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain. Electronic address: j.i.borrell@iqs.url.edu., Roué G; Lymphoma Translational Group, UBIRed, Josep Carreras Leukaemia Research Institute, Badalona, Spain. Electronic address: groue@carrerasresearch.org.
Publikováno v:
Seminars in cell & developmental biology [Semin Cell Dev Biol] 2022 Dec; Vol. 132, pp. 213-229. Date of Electronic Publication: 2022 Feb 17.